Packaging and storage
Preserve in single-dose containers,as described under
Injections á1ñ.Maintain in the frozen state.
Labeling
It meets the requirements for
Labelingunder
Injections á1ñ.The label states that it is to be thawed just prior to use,describes conditions for proper storage of the resultant solution,and directs that the solution is not to be refrozen.
Identification
The chromatogram of the
Assay preparationobtained as directed in the
Assayexhibits a major peak for cefotaxime,the retention time of which corresponds to that exhibited in the chromatogram of the
Standard preparationobtained as directed in the
Assay.
Chromatographic purity
Using the chromatogram of the
Assay preparationobtained in the
Assay,calculate the percentage of each impurity by the formula:
100ri/(ris+rc),
in which
riis the peak area response of a given impurity,
risis the sum of all of the impurity peak area responses,and
rcis the peak area response for the main cefotaxime peak.
[NOTEDisregard any impurity peak that is less than 0.1%.
]Not more than 6.0%of any individual impurity is found,and the sum of all impurities found is not more than 10.0%.
Assay
0.05M Phosphate buffer,Solution A,Solution B,Mobile phase,Standard preparation,Resolution solution,and Chromatographic system
Prepare as directed in the
Assayunder
Cefotaxime Sodium.
Assay preparation
Allow 1container of Injection to thaw,and mix.Transfer an accurately measured volume of the Injection,equivalent to about 80mg of cefotaxime (C16H17N5O7S2),to a 100-mLvolumetric flask,dilute with Solution Ato volume,and mix.
Procedure
Proceed as directed for
Procedurein the
Assayunder
Cefotaxime Sodium.Calculate the quantity,in mg,of cefotaxime (C
16H
17N
5O
7S
2)in each mLof the Injection taken by the formula:
0.1(CP/V)(rU/rS),
in which
Vis the volume,in mL,of Injection taken,to prepare the
Assay preparation,and the other terms are as defined therein.